Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 55,000 shares at $15.92 ($876K) on 2025-07-21, disclosed to the SEC on 2025-07-21.
Scheduled sale ($876k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |
| CLVT | BUY | 2025-03-05 | $508K | — | Filing → |